Svelte Medical Systems
Delivers novel products in the coronary stent market to curb key clinical issues by improving stent deliverability.
Launch date
Employees
Market cap
-
Enterprise valuation
$20—30m (Dealroom.co estimates Mar 2014.)
New Providence Iowa (HQ)
Authorizing premium user...